S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
$30.87
$30.75
$16.36
$30.91
$497.25M0.7390,796 shsN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$14.00
+1.8%
$14.53
$3.80
$18.15
$367.92M2.08106,465 shs65,350 shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$7.80
-0.3%
$8.87
$5.90
$12.01
$302.33M1.51160,921 shs129,123 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
0.00%0.00%0.00%0.00%0.00%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-2.07%-5.30%+7.09%+3.77%+197.62%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
-5.33%-2.49%-18.20%+2.62%-25.10%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
N/AN/AN/AN/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.4233 of 5 stars
3.43.00.00.01.94.20.0
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
N/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.86
Moderate Buy$15.6711.90% Upside
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/A

Current Analyst Ratings

Latest VMD, NPCE, ITMR, and CREO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/14/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$16.00 ➝ $20.00
3/6/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $13.00
3/6/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$16.00 ➝ $18.00
2/22/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $16.00
1/30/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
1/30/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$22.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
$41.03M12.12N/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$65.42M5.62N/AN/A$0.79 per share17.72
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$183.01M1.65$0.79 per share9.91$2.96 per share2.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
N/A-$1.35N/AN/AN/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$32.96M-$1.28N/AN/AN/A-50.38%-153.76%-31.73%5/8/2024 (Confirmed)
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$10.24M$0.2630.00N/A5.60%9.59%7.09%5/13/2024 (Estimated)

Latest VMD, NPCE, ITMR, and CREO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.32N/A+$0.32N/AN/AN/A  
3/6/2024Q4 2023
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/A$0.09+$0.09$0.09N/A$50.74 million
3/5/2024Q4 2023
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.33-$0.23+$0.10-$0.23$17.74 million$18.01 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
N/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.76
5.71
5.02
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.05
1.19
1.05

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
42.19%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
74.24%

Insider Ownership

CompanyInsider Ownership
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
27.50%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
19.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Itamar Medical Ltd. stock logo
ITMR
Itamar Medical
25716.11 millionN/ANot Optionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17126.28 million19.06 millionOptionable
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
99638.76 million31.32 millionNot Optionable

VMD, NPCE, ITMR, and CREO Headlines

SourceHeadline
Viemed Healthcare: Long-Term Bull Remains Intact But Patience RequiredViemed Healthcare: Long-Term Bull Remains Intact But Patience Required
seekingalpha.com - April 17 at 8:27 AM
Triasima Portfolio Management inc. Trims Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)Triasima Portfolio Management inc. Trims Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)
marketbeat.com - April 14 at 11:11 AM
Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Grows By 100.6%Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Grows By 100.6%
americanbankingnews.com - April 11 at 2:52 AM
Analysts Offer Insights on Healthcare Companies: Silk Road Medical (SILK) and Viemed Healthcare (VMD)Analysts Offer Insights on Healthcare Companies: Silk Road Medical (SILK) and Viemed Healthcare (VMD)
markets.businessinsider.com - April 3 at 2:01 PM
Viemed gets controlling interest in Alabama HMEViemed gets controlling interest in Alabama HME
hmenews.com - April 2 at 2:00 PM
Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama HealthViemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health
globenewswire.com - April 2 at 9:00 AM
Viemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call TranscriptViemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 9 at 4:47 PM
VMD stock wins price target raise at BeaconVMD stock wins price target raise at Beacon
cantechletter.com - March 7 at 4:59 PM
Viemed Healthcare Inc (VMD) Reports Record Financial Results for 2023Viemed Healthcare Inc (VMD) Reports Record Financial Results for 2023
finance.yahoo.com - March 7 at 3:41 PM
VMD Stock Earnings: Viemed Healthcare Misses EPS, Beats Revenue for Q4 2023VMD Stock Earnings: Viemed Healthcare Misses EPS, Beats Revenue for Q4 2023
msn.com - March 6 at 11:30 PM
Viemed Healthcare Announces Record 2023 Financial ResultsViemed Healthcare Announces Record 2023 Financial Results
globenewswire.com - March 6 at 5:00 PM
Heres what Wall Street expects from Viemed Healthcares earnings reportHere's what Wall Street expects from Viemed Healthcare's earnings report
markets.businessinsider.com - March 5 at 10:59 AM
Viemed Healthcare Inc.Viemed Healthcare Inc.
wsj.com - February 22 at 9:29 PM
Viemed Healthcare Announces Date and Time for Conference CallViemed Healthcare Announces Date and Time for Conference Call
globenewswire.com - February 20 at 4:30 PM
Investors in Viemed Healthcare (NASDAQ:VMD) have seen decent returns of 83% over the past five yearsInvestors in Viemed Healthcare (NASDAQ:VMD) have seen decent returns of 83% over the past five years
finance.yahoo.com - January 10 at 7:09 AM
Should You Hold Viemed Healthcare (VMD)?Should You Hold Viemed Healthcare (VMD)?
finance.yahoo.com - December 26 at 9:21 AM
Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?
finance.yahoo.com - December 24 at 11:59 AM
Viemed Healthcare Inc Ordinary SharesViemed Healthcare Inc Ordinary Shares
morningstar.com - December 21 at 10:01 AM
Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?
finance.yahoo.com - November 18 at 8:51 AM
Viemed Healthcare Inc Ordinary Shares VMDViemed Healthcare Inc Ordinary Shares VMD
morningstar.com - November 11 at 5:04 AM
Viemed Healthcare to Present at Stifel 2023 Healthcare ConferenceViemed Healthcare to Present at Stifel 2023 Healthcare Conference
finance.yahoo.com - November 7 at 9:40 AM
Viemed Healthcare, Inc.: Viemed Healthcare Announces Record Third Quarter 2023 Financial ResultsViemed Healthcare, Inc.: Viemed Healthcare Announces Record Third Quarter 2023 Financial Results
finanznachrichten.de - November 2 at 7:42 AM
Viemed Healthcare Announces Record Third Quarter 2023 Financial ResultsViemed Healthcare Announces Record Third Quarter 2023 Financial Results
finance.yahoo.com - November 1 at 6:12 PM
Viemed Healthcare Q3 2023 Earnings PreviewViemed Healthcare Q3 2023 Earnings Preview
msn.com - October 31 at 6:12 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Itamar Medical logo

Itamar Medical

NASDAQ:ITMR
Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.
NeuroPace logo

NeuroPace

NASDAQ:NPCE
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Viemed Healthcare logo

Viemed Healthcare

NASDAQ:VMD
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.